A comparison of the incidence of midline catheter–associated bloodstream infections to that of central line–associated bloodstream infections in 5 acute care hospitals - 26/08/20
Doi : 10.1016/j.ajic.2019.11.004
Nancy J. Hogle, MPH, RN, CIC a, ⁎ 
, Krystal M. Balzer, MSN, RN, CIC a, Barbara G. Ross, MS, RN, CIC, FAPIC a, Lorelle Wuerz, PhD, RN, VA-BC, NEA-BC b, William G. Greendyke, MD a, c, E. Yoko Furuya, MD, MS a, c, Matthew S. Simon, MD, MS a, d, David P. Calfee, MD, MS a, d
, Krystal M. Balzer, MSN, RN, CIC a, Barbara G. Ross, MS, RN, CIC, FAPIC a, Lorelle Wuerz, PhD, RN, VA-BC, NEA-BC b, William G. Greendyke, MD a, c, E. Yoko Furuya, MD, MS a, c, Matthew S. Simon, MD, MS a, d, David P. Calfee, MD, MS a, d a Department of Infection Prevention and Control, NewYork-Presbyterian Hospital, New York, NY
b Center for Professional Nursing Practice, NewYork-Presbyterian, New York, NY
c Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY
d Department of Medicine, Weill Cornell Medicine, New York, NY
⁎Address correspondence to Nancy J. Hogle, MPH, Cleveland Clinic, 9500 Euclid Ave, JJN2-200, Cleveland, OH 44195.Cleveland Clinic9500 Euclid Ave, JJN2-200ClevelandOH44195
Résumé |
In a retrospective study conducted over 12 months in a multi-hospital system, the incidence of bloodstream infections associated with midline catheters was not significantly lower than that associated with central venous catheters (0.88 vs 1.10 infections per 1,000 catheter-days). Additional research is needed to further characterize the infectious risks of midline catheters and to determine optimal strategies to minimize these risks.
Le texte complet de cet article est disponible en PDF.Key Words : Intravenous therapy, Blood stream infection, Bacteremia, Intravascular catheter
Plan
| Conflicts of interest: M.S.S. reports personal fees from Roche Diagnostics, outside the submitted work. All other authors report no conflicts of interest. |
© 2019
Association for Professionals in Infection Control and Epidemiology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 48 - N° 9
P. 1108-1110 - septembre 2020 Retour au numéro
Article précédent
- Holding firm: Use of clinical correlation to improve Clostridioides difficile testing
- Jonathan Baghdadi, David A. Ganz, Maryanne Chumpia, Evelyn T. Chang, Shelly S. de Peralta
- Nasal decolonization of Staphylococcus aureus in orthopedic surgeons using mupirocin and chlorhexidine
- Ana Gabriela Castro-Martínez, Elvira Garza-González, Víctor Peña-Martínez, Juan Sebastian Gonzalez-Bracamonte, Adrián Camacho-Ortiz
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?